Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases

Journal of Nutritional Biochemistry

Volumn 24, Issue 6, 2013, Pages 977-985

  Berger, Alexander ^a   Venturelli, Sascha ^a   Kallnischkies, Mascha ^b   Böcker, Alexander ^c   Busch, Christian ^a   Weiland, Timo ^a   Noor, Seema ^a   Leischner, Christian ^a   Weiss, Thomas S ^d   Lauer, Ulrich M ^a   Bischoff, Stephan C ^b   Bitzer, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c EVOTEC AG   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Epigenetics; Flavonoid; Histone deacetylase; Kaempferol; Polyphenol

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; KAEMPFEROL;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CHICKEN; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DIETARY INTAKE; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; EMBRYO; EMBRYOTOXICITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; EPIGENETICS; HEPATOMA CELL; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LIVER CELL; MITOSIS INHIBITION; MOLECULAR DOCKING; NONHUMAN; OXIDATIVE STRESS;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHICK EMBRYO; COMPUTER SIMULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; KAEMPFEROLS; LIVER; MOLECULAR DOCKING SIMULATION;

ANIMALIA;

EID: 84878020157     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.07.001     Document Type: Article

References (40)

1. Hodek P., Trefil P., Stiborová M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002, 139:1-21.
2. Pietta P.G. Flavonoids as antioxidants. J Nat Prod 2000, 63:1035-1042.
3. Haslam E. Practical polyphenolics. From structure to molecular recognition and physiological action 1998, Cambridge, U.K., Cambridge University Press.
4. Clere N., Faure S., Martinez M.C., Andriantsitohaina R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 2011, 9:62-77.
5. Nishiumi S., Miyamoto S., Kawabata K., Ohnishi K., Mukai R., Murakami A., et al. Dietary flavonoids as cancer-preventive and therapeutic biofactors. Front Biosci 2011, 3:1332-1362.
6. Calderón-Montaño J.M., Burgos-Morón E., Pérez-Guerrero C., López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 2011, 11:298-344.
7. Stewart A.J., Bozonnet S., Mullen W., Jenkins G.I., Lean M.E., Crozier A. Occurrence of flavonols in tomatoes and tomato-based products. J Agric Food Chem 2000, 48:2663-2669.
8. Jaganathan S.K., Mandal M. Antiproliferative effects of honey and of its polyphenols: a review. J Biomed Biotechnol 2009.
9. Zhang Y., Seeram N.P., Lee R., Feng L., Heber D. Isolation and identification of strawberry phenolics with antioxidant and human cancer cell antiproliferative properties. J Agric Food Chem 2008, 56:670-675.
10. Kang J.W., Kim J.H., Song K., Kim S.H., Yoon J.H., Kim K.S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res 2010, 1:77-82.
11. Bajpai M., Pande A., Tewari S.K., Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr 2005, 56:287-291.
12. Park J.S., Rho H.S., Kim D.H., Chang I.S. Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity. J Agric Food Chem 2006, 54:2951-2956.
13. Leung H.W., Lin C.J., Hour M.J., Yang W.H., et al. Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem Toxicol 2007, 45:2005-2013.
14. Marfe G., Tafani M., Indelicato M., Sinibaldi-Salimei P., Reali V., Pucci B., et al. Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem 2009, 106:643-650.
15. De Leo M., Braca A., Sanogo R., Cardile V., et al. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med 2006, 72:604-610.
16. Kim K.S., Rhee K.H., Yoon J.H., Lee J.G., et al. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol 2005, 41:383-389.
17. Mutoh M., Takahashi M., Fukuda K., Matsushima-Hibiya Y., et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000, 21:959-963.
18. Eun J.C., Woong S.A. Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr Res Prac 2008, 2:322-325.
19. Huang W.W., Chiu Y.J., Fan M.J., Lu H.F., Yeh H.F., Li K.H., et al. Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells. Mol Nutr Food Res 2010, 54:1585-1595.
20. Lara K.P., Simonetta F., Sang-Woon C. Nutritional influences on epigenetics and age-related disease 2011.
21. Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002, 1:287-299.
22. Mai A. The therapeutic uses of chromatin-modifying agents. Expert Opin Ther Targets 2007, 11:835-851.
23. Thasler W.E., Weiss T.S., Schillhorn K., Stoll P.T., Irrgang B., Jauch K.W. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank 2003, 4:49-56.
24. Armeanu S., Krusch M., Baltz K.M., Weiss T.S., Smirnow I., Steinle A., et al. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clin Cancer Res 2008, 14:3520-3528.
25. Abassi Y.A., Xi B., Zhang W., Ye P., Kirstein S.L., Gaylord M.R., et al. Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem Biol 2009, 16:712-723.
26. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107-1112.
27. Hamburger V., Hamilton H.L. A series of normal stages in the development of the chick embryo.1951. Dev Dyn 1992, 195:231-272.
28. Fechner S., Busch C., Oppitz M., Drews U., Meyer-Wittkopf M. The chick embryo as a model for intrauterine ultrasound-guided heart intervention. Ultrasound Obstet Gynecol 2008, 31:277-283.
29. Clark A.M., Labute P. 2D depiction of protein-ligand complexes. J Chem Inf Model 2007, 47:1933-1944.
30. Lee T.K., Lau T.C., Ng I.O. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother Pharmacol 2002, 49:78-86.
31. Venturelli S., Berger A., Weiland T., Zimmermann M., Häcker S., Peter C., et al. Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulation. Gut 2011, 60:156-165.
32. Weiland T., Berger A., Essmann F., Lauer U.M., Bitzer M., Venturelli S. Kinetic tracking of therapy-induced senescence using the real-time cell analyzer SP system. Assay Drug Dev Technol 2012, 10:289-295.
33. Ellis L., Atadja P.W., Johnstone R.W. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 2009, 8:1409-1420.
34. Meeran S.M., Ahmed A., Tollefsbol T.O. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 2010, 1:101-116.
35. Ho E., Dashwood R.H. Dietary manipulation of histone structure and function. World Rev Nutr Diet 2010, 101:95-102.
36. Gilbert E.R., Liu D. Flavonoids influence epigenetic-modifying enzyme activity: structure-function relationships and the therapeutic potential for cancer. Curr Med Chem 2010, 17:1756-1768.
37. Dashwood R.H., Myzak M.C., Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 2006, 27:344-349.
38. Li N., Liu J.H., Zhang J., Yu B.Y. Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J Agric Food Chem 2008, 56:3876-3883.
39. DuPont M.S., Day A.J., Bennett R.N., Mellon F.A., Kroon P.A. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr 2004, 58:947-954.
40. López-Sánchez C., Martín-Romero F.J., Sun F., Luis L., Samhan-Arias A.K., García-Martínez V., et al. Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusion-induced damage in rat brain. Brain Res 2007, 1182:123-137.